Key result
Pentaerythritol tetranitrate prevents angina pain in ~78% of patients.
Why the study?
Glyceryl trinitrate promptly relieves the pain of angina pectoris, but its prophylactic value is limited by its short duration of action, prompting efforts to find a long-acting drug such as pentaerythritol tetranitrate to prevent anginal pain.
Answers are grounded in this paper and cite their sources.
Supports PETN for angina symptom relief; leaves open confirmation in randomized trials before practice change.
Although many drugs have been advocated for the treatment of angina pectoris, only the nitrites have proved unequivocally useful. Glyceryl trinitrate (nitroglycerin) promptly relieves the pain of angina pectoris, but its value as a prophylactic agent is limited by the short duration of its action. For this reason, various related compounds have been developed in an effort to find a long-acting drug which would prevent anginal pain. Von Oettingen and his co-workers1studied the pharmacology and toxicity of pentaerythritol (Peritrate) tetranitrate in 1944. Subsequently, several favorable reports on its use in angina pectoris were published in Europe.* Winsor and Humphreys4studied the effect of pentaerythritol tetranitrate on 125 patients who had angina pectoris. They found that an average dose of 10 mg. three times daily produced satisfactory prevention of precordial pain in 78.4% of the patients. Glyceryl trinitrate requirement was reduced; exercise tolerance was increased, and the S-T
No takes yet. Share an insight, caveat, or question.
GEORGE M. KALMANSON (1955) studied Angina pectoris. Pentaerythritol tetranitrate (Peritrate) was evaluated on Satisfactory prevention of precordial pain (in prior cited study). Pentaerythritol tetranitrate produced satisfactory prevention of precordial pain in 78.4% of 125 angina pectoris patients in a cited study.
Synapse has enriched 10 related papers. Consider them for comparative context: